OVERVIEW

An AAN 2019 Multiple Sclerosis Update is organized by AcademicCME.

Start Date: 07-11-2019
Expires: 07-11-2020

Accreditation:
• AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.
• AcademicCME designates this enduring material for a maximum of 1.0 CNE contact hour (1.0 CNE pharmacotherapeutic contact hour).

Description:
This CME/CNE activity will provide a comprehensive update of best practices for treating and managing patients with multiple sclerosis (MS), including data presented at American Academy of Neurology (AAN) 2019 Annual Meeting. The expert faculty will review strategies for early detection and intervention in MS, referencing the McDonald Criteria. Recent clinical trial data, including extension data of emerging and emerged therapeutic agents will be analyzed. The clinical relevance of neurofilament light chain (NfL) in modern day multiple sclerosis care will be debated in an interactive panel format. The faculty will relay optimal strategies for providing personalized care. Upon completion of this education, learners will be better equipped to confidently treat and manage patients with multiple sclerosis.

Objectives:
• Understand the role of immune-inflammation in relapsing multiple sclerosis, as well as diagnostic criteria for the disease
• Analyze clinical trial data of novel S1P therapeutics to treat relapsing multiple sclerosis, including data presented at AAN 2019
• Collaborate with the interprofessional team to develop individualized treatment plans to decrease disease activity and improve the overall quality of life of patients with relapsing multiple sclerosis

Additional details will be posted as soon as information is available.